Laekna Therapeutics is the founder of Laekna Therapeutics. Latest round: Series B. Based in Shanghai, China.
Chris Lu is the founder and CEO of Laekna Therapeutics, a clinical-stage biotechnology company established in 2016. Laekna Therapeutics specializes in the research and development of anti-cancer drugs and is headquartered in Shanghai, China, having raised significant funding, including a $27.5 million Series B round, and gone public on the Hong Kong Stock Exchange.
Full founder directory · Investor directory · Company funding database · Fundraising library